{"id":20267290,"updated":"2026-03-16T15:18:59Z","additionalIndexing":"2841;15;52","affairType":{"abbreviation":"Fra.","id":14,"name":"Fragestunde. Frage"},"author":{"councillor":{"code":3190,"gender":"f","id":4298,"name":"Weichelt Manuela","officialDenomination":"Weichelt"},"type":"author"},"deposit":{"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2026-03-11T00:00:00Z","legislativePeriod":52,"session":"5212"},"descriptors":[],"drafts":[{"consultation":{"resolutions":[{"category":{"id":3,"name":"Normal"},"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2026-03-16T00:00:00Z","text":"Mündliche Beantwortung der Frage","type":82}]},"federalCouncilProposal":{},"index":0,"links":[],"preConsultations":[],"references":[],"relatedDepartments":[{"abbreviation":"EDI","id":4,"name":"Departement des Innern","leading":true}],"states":[{"date":"\/Date(1773183600000+0100)\/","id":202,"name":"Eingereicht"},{"date":"\/Date(1773615600000+0100)\/","id":229,"name":"Erledigt"}],"texts":[]}],"language":"de","priorityCouncils":[{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N","priority":1}],"relatedAffairs":[],"roles":[{"councillor":{"code":3190,"gender":"f","id":4298,"name":"Weichelt Manuela","officialDenomination":"Weichelt"},"type":"author"}],"shortId":"26.7290","state":{"id":229,"name":"Erledigt","doneKey":"0","newKey":1},"texts":[{"type":{"id":5,"name":"Eingereichter Text"},"value":"<p>Der Hersteller hat Estradot (Östrogenpflaster) von der SL genommen, da er nicht den gemäss BAG überhöhten Preis erhalten hat. Die Alternativen sind jedoch aus ökologischen Gründen abzulehnen (Verunreinigung unserer Gewässer).<br>Ist der Bundesrat bereit, die Gesetzgebung insofern zu ändern, dass für die Preisgestaltung ökologische Aspekte miteinfliessen?<\/p>"},{"type":{"id":1,"name":"Titel des Geschäftes"},"value":"Ökologie als Teil der Preisbildung bei Medikamenten"}],"title":"Ökologie als Teil der Preisbildung bei Medikamenten"}